Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eastern Cooperative Oncology Group
National Institutes of Health Clinical Center (CC)
University of Nebraska
Novartis
Brigham and Women's Hospital
National Institutes of Health Clinical Center (CC)
University of Cincinnati
Massachusetts Eye and Ear Infirmary
Merck Sharp & Dohme LLC
Cardiff University
Xiamen University
Jonsson Comprehensive Cancer Center
Instituto do Cancer do Estado de São Paulo
AIDS Malignancy Consortium
Ohio State University Comprehensive Cancer Center
Institut du Cancer de Montpellier - Val d'Aurelle
Centre Hospitalier Universitaire de Besancon
Shanghai Bovax Biotechnology Co., Ltd.
University of Cincinnati
Goethe University
Aarhus University Hospital
Aarhus University Hospital
Beijing Health Guard Biotechnology, Inc